Alkaline Corporation

Form 483 issued September 6, 2024 · Eatontown, New Jersey

Inspection
Feb 15 – Sep 6, 2024
Investigator
Frederick Razzaghi
Observations
7
Pages
4
FEI number
1000526882

In short: On September 6, 2024, FDA issued a Form 483 with 7 observations to Alkaline Corporation in Eatontown, New Jersey (FEI 1000526882) after an inspection that ran Feb 15 – Sep 6, 2024. The investigator was Frederick Razzaghi. Most observations concern materials and quality system; the most-cited regulation is 21 CFR 211.84 (testing and approval or rejection of components, drug product containers, and closures).

At a glance

Observations span 4 systems, led by materials.

Materials2
Quality system1
Laboratory controls1
Production1
Other2

What FDA observed

Preview: the opening words of each observation
  1. 01

    There is no quality…

  2. 02

    Establishment of the reliability of the component supplier's report of analyses is deficient in that the…

  3. 03

    There is no written testing program designed to assess the stability…

  4. 04

    Batch production and control records are not prepared for each batch of drug product produced and…

3 more observations

Plus the full detail behind each one, exactly as FDA wrote it.

Get the full 483

This inspection in context

Questions about this 483

What did FDA find at Alkaline Corporation?

FDA listed 7 observations on this Form 483, mostly about materials, quality system and laboratory controls. The most-cited regulation is 21 CFR 211.84 (testing and approval or rejection of components, drug product containers, and closures). The opening words of each observation are shown on this page.

Who inspected Alkaline Corporation?

Frederick Razzaghi is named on this Form 483, for the inspection of Feb 15 – Sep 6, 2024. Each investigator has a profile showing what they cite most.

When was Alkaline Corporation inspected by FDA?

The inspection ran Feb 15 – Sep 6, 2024, and the Form 483 is dated September 6, 2024.

How do I get the full Form 483 for Alkaline Corporation?

Download the original PDF from FDA Intel for $99, with no subscription. Your first Form 483 or letter is on us. You also get an invoice PDF with the order.

$99Get it free